Skip to main content

Table 1 Determinants of the primary Lesion SUVmax among cases

From: Correlation of primary tumor metabolic parameters with clinical, histopathological and molecular characteristics in breast cancer patients at pre-operative staging FDG-PET/CT study

  Lesion SUVmax P-value
Mean ± SD Median (IQR)
Pathology    
• IDC(n=36) 3.96±3.1 2.85(3.33) =0.258#
• ILC(n=3) 2.41±2.98 0.8
• Other (n=1) 1  
Menopausal State    
• Pre- (n=19) 14.55 ± 2.1 13 (6) 0.003*
• Post- (n=21) 7.45 ± 1.0 7 (2)
Disease Stage    
• I & II (n=27) 8.79 ± 1.1 7 (2) = 0.017*
• III & IV (n=13) 15.06 ± 2.9 14 (5)
ER-Receptors    
Positive (n=31) 9.12 ± 5.7 7 (6) = 0.010**
Negative (n=9) 16.70 ± 9.6 12.5 (11)
PR-Receptors    
Positive (n=24) 9.13 ± 6.2 7 (5) = 0.113**
Negative (n=16) 13.37 ± 9.7 9 (8.5)
Her2-neu Receptors    
Positive (n=14) 12.35 ± 5.8 13 (9.5) =0.089**
Negative (n=26) 10.01 ± 8.9 7 (6.5)
Tumor grad
GI (n=5) 3.69±1.4 3.1(2.6)  
GII (n=18) 9.43±6.11 6.85(11.08) =0.002#
GIII (n=15) 15.03±9.20 11.11(13.4)  
Molecular subtype    
Luminal A (n=10) 5.88±4.9 4.18(5.06) 0.007#
Luminal B (n=19) 10.93±5.55 8.4(9)
Her2neu over expression (n=4) 8.03±5.24 7.98(9.13)
Triple negative (n=7) 19.19±11.86 21.6(17.67)
Axillary LN State
Positive (n=27) 12.80 ± 8.6 10 (8.5) = 0.016**
Negative(n=13) 6.73 ± 4.1 6.5 (6)
  1. *Independent t-test
  2. **Mann Whitney U
  3. # Kruskal Wallis test